Sangyoon Y. Ko

Sangyoon Y. Ko

Auto-generated profile, based on publicly available information

Sangyoon Y. Ko

Program in Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2023 in Science
Verified
Journal Article
Closed access
ARAdam I. Ramsaran
Adam I. Ramsaran
YWYing Wang
Ying Wang
AGAli Golbabaei
Ali Golbabaei
SAStepan Aleshin
Stepan Aleshin
MSMitchell L. de Snoo
Mitchell L. de Snoo
PFPaul W. Frankland
Paul W. Frankland
The ability to form precise, episodic memories develops with age, with young children only able to form gist-like memories that lack precision. The cellular and molecular events in the developing hippocampus that underlie the emergence of precise, episodic-like memory are unclear. In mice, the absence of a competitive neuronal engram allocation process in the immature hippocampus precluded the formation of sparse engrams and precise memories until the fourth postnatal week, when inhibitory circuits in the hippocampus mature. This age-dependent shift in precision of episodic-like memories involved the functional maturation of parvalbumin-expressing interneurons in subfield CA1 through assembly of extracellular perineuronal nets, which is necessary and sufficient for the onset of competitive neuronal allocation, sparse engram formation, and memory precision.

14 May 2025 in Nature
Verified
Journal Article
Closed access
PDF file
SKSangyoon Y. Ko
Sangyoon Y. Ko
YRYiming Rong
Yiming Rong
ARAdam I. Ramsaran
Adam I. Ramsaran
XCXiaoyu Chen
Xiaoyu Chen
ARAsim J. Rashid
Asim J. Rashid
PFPaul W. Frankland
Paul W. Frankland

17 March 2022 in Genes
Verified
Journal Article
Open access
PDF file
SPStephen F. Pastore
Stephen F. Pastore
SKSangyoon Y. Ko
Sangyoon Y. Ko
PFPaul W. Frankland
Paul W. Frankland
PHPaul A. Hamel
Paul A. Hamel
JVJohn B Vincent
John B Vincent
Over the last one and a half decades, copy number variation and whole-genome sequencing studies have illuminated the considerable genetic heterogeneity that underlies the etiologies of autism spectrum disorder (ASD) and intellectual disability (ID). These investigations support the idea that ASD may result from complex interactions between susceptibility-related genetic variants (single nucleotide variants or copy number variants) and the environment. This review outlines the identification and neurobiological characterization of two such genes located in Xp22.11, Patched domain-containing 1 (PTCHD1), and its antisense lncRNA PTCHD1-AS. Animal models of Ptchd1 disruption have recapitulated a subset of clinical symptoms related to ASD as well as to ID. Furthermore, these Ptchd1 mouse knockout studies implicate the expression of Ptchd1 in both the thalamic and the hippocampal brain regions as being crucial for proper neurodevelopment and cognitive function. Altered kynurenine metabolic signalling has been postulated as a disease mechanism in one of these animal studies. Additionally, ASD patient-derived induced pluripotent stem cells (iPSCs) carrying a copy number loss impacting the antisense non-coding RNA PTCHD1-AS have been used to generate 2D neuronal cultures. While copy number loss of PTCHD1-AS does not affect the transcription of PTCHD1, the neurons exhibit diminished miniature excitatory postsynaptic current frequency, supporting its role in ASD etiology. A more thorough understanding of risk factor genes, such as PTCHD1 and PTCHD1-AS, will help to clarify the intricate genetic and biological mechanisms that underlie ASD and ID, providing a foundation for meaningful therapeutic interventions to enhance the quality of life of individuals who experience these conditions.

13 May 2026 in Nature
Verified
Journal Article
Open access
PDF file
CBClarrisa A. Bradley
Clarrisa A. Bradley
SKSangyoon Y. Ko
Sangyoon Y. Ko
MTMeng Tian
Meng Tian
LRLiam T. Ralph
Liam T. Ralph
LDLia D’ABate
Lia D’ABate
SSStephan Scherer
Stephan Scherer
There are around 100 genes or copy-number variations used in genetic testing for autism spectrum disorder (ASD)1,2. The established genes are protein coding, and the associated phenotypes usually extend beyond sociobehavioural traits seen in autism, including cognitive/medical complexities and attention deficit hyperactivity disorder (ADHD)3,4. We examined whole-genome sequencing data in cases of ASD (9,349) and controls (8,332) and identify 27 male individuals with ASD with X-chromosome microdeletions that implicate the long non-coding RNA PTCHD1-AS as an ASD-susceptibility gene (odds ratio = 2.56, P = 0.01). Two Ptchd1-as-knockout mouse models, which were created by disrupting/deleting the evolutionarily conserved exon 3, show ASD-like features in male mice, including increased repetitive behaviours and impaired social behaviour and communication without cognitive comorbidities or ADHD-like behaviours. Hippocampus-dependent synaptic function, complex learning and locomotor activity are unaffected in knockout mice. Native nuclear-enriched mouse Ptchd1-as showed sustained expression from postnatal day 7 onwards in the dorsal striatum, a predominantly GABAergic brain region that is implicated in ASD5. Multi-omics analysis revealed transcriptomic alterations in striatal oligodendrocytes, astrocytes and neurons impacting myelination and synaptic plasticity. Disrupting Ptchd1-as led to reductions in conventional protein kinase C (cPKC) isoforms, altered SRC and GSK-3α/β phosphorylation and enhanced striatal synaptic plasticity (long-term potentiation and long-term depression). Together, these findings implicate striatal molecular and circuit-level dysregulation through PTCHD1-AS in ASD aetiology.

16 June 2026 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
SKSangyoon Y. Ko
Sangyoon Y. Ko
SPStephen F. Pastore
Stephen F. Pastore
SPSungmo Park
Sungmo Park
JEJonathan R. Epp
Jonathan R. Epp
AMAnna Mikhailov
Anna Mikhailov
PFPaul W. Frankland
Paul W. Frankland